SCHEMBL29986820

SCHEMBL29986820

Cc1nn(C)c2cc(N3CCC(CO)CC3)c(NC(=O)c3coc(-c4ccnc(N)c4)n3)cc12

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16899021 1.00 IRAK4 (0.67) IRAK4
SCHEMBL17383337 0.98 IRAK4 (0.68) IRAK4
Hydrochloric Acid SCHEMBL17373858 0.97 IRAK4 (0.67) IRAK4
SCHEMBL16899228 0.93 IRAK4 (0.57) IRAK4
SCHEMBL18392003 0.92 IRAK4 (0.57) IRAK4
SCHEMBL18392002 0.91 IRAK4 (0.56) IRAK4
SCHEMBL17383349 0.91 IRAK4 (0.57) IRAK4
SCHEMBL18391950 0.91 IRAK4 (0.62) IRAK4
Hydrochloric Acid SCHEMBL17373933 0.90 IRAK4 (0.57) IRAK4
SCHEMBL16899238 0.89 IRAK4 (0.54) IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4319750-A1 COMBINATION THERAPIES FOR THE TREATMENT OF CANCER Curis, Inc. (US) 2024-02-14 — — EP claimed
CN-117120054-A Combination therapy for the treatment of cancer 柯里斯公司 2023-11-24 — — CN claimed
WO-2022216379-A1 COMBINATION THERAPIES FOR THE TREATMENT OF CANCER CURIS, INC. (US) 2022-10-13 — — WO claimed
Send feedback